Full Press Release Details
Revolutionizing Surgery: SS Innovations International
Inc. Celebrates 2,000 Procedures with its SSi Mantra Surgical Robotic System
Fort Lauderdale, FL., September 23
2024 - SS Innovations International, Inc. (the Company" or "SS Innovations") (OTC: SSII), developer of
innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global
population, announced that it has now successfully completed over 2,000 robotic surgeries, primarily in India, using its SSi Mantra
Surgical Robotic System (the "SSi Mantra").
The significance of the 2,000 surgeries extends
beyond mere numbers; it embodies a critical response to a pressing need in the medical community. As global disparities in healthcare
persist, SS Innovations has emerged as a leader in providing advanced surgical solutions that are accessible to all. The Company's
guiding principles of "democratizing access" and "decentralizing excellence" reflect its dedication to making
world-class healthcare attainable for every patient, irrespective of their socio-economic background.
The SSi Mantra's impact is already being
felt in hospitals throughout India where it has been installed. Surgeons have praised its ergonomic design and precise controls, which
facilitate minimally invasive procedures and improve patient outcomes. By minimizing recovery time and reducing the risk of complications,
the SSi Mantra has become an invaluable tool in surgical suites, particularly in resource-constrained environments where access to advanced
technologies has historically been limited due to the relative exorbitant cost associated with such technology.
Notably, the SSi Mantra has also been installed
in many Tier 2 and Tier 3 cities across India, including Moradabad, Hisar, Coimbatore, Rohtak, and Cuttack, where communities are now
reaping the benefits of innovative surgical technologies. Furthermore, the SSi Mantra also marks a significant milestone as Nepal's
first surgical robot, bringing renewed hope for advanced medical care to that nation.
Among the 2,000 surgeries performed, 123 were
cardiac cases. Each procedure addresses varying complexities, highlighting the system's versatility and adaptability in handling intricate
surgical procedures.
To celebrate this milestone, SS Innovations Founder,
Chairman, and CEO, Dr. Sudhir Srivastava expressed his gratitude to the entire team. "It is the spirit of our engineers, their faith
in the system, and their commitment to improving lives that has brought us this far".
Dr. Vishwa Srivastava, President and COO of SS
Innovations, remarked, "Our mission as a digital healthcare company is to democratize global access to the latest technologies.
This milestone underscores the impact of our innovations and drives us forward in our journey to improve surgical outcomes globally."
The success of the SSi Mantra Surgical Robotic
System in India has resulted in robust quality and safety data as well as clinical patient-centric outcomes. This should be helpful in
not only continuing SS Innovation's mission to provide quality care to patients across the globe but also of value in seeking further
regulatory approval in other markets.
About SS Innovations International, Inc.:
SS Innovations International, Inc. (OTC: SSII)
is a developer of innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible
to a larger part of the global population. SSII's product range includes its proprietary "SSi Mantra" surgical robotic
system, and "SSi Mudra" its wide range of surgical instruments capable of supporting a variety of surgical procedures including
robotic cardiac surgery. SSII's business operations are headquartered in India and SSII has plans to expand the presence of its
technologically advanced, user-friendly, and cost-effective surgical robotic solutions, globally. For more information, visit SSII's
website at sinnovations.com or LinkedIn for updates.
Supporting advanced, affordable, and accessible
robotic surgery, the SSi Mantra Surgical Robotic System provides the capabilities for multi-specialty usage including cardiothoracic,
head and neck, gynecology, urology, general surgery and more. With its modular arm configuration, 3D 4K vision open-console design and
superior ergonomics, the system engages with the surgeon and surgical teams to improve safety and efficiency during procedures. The SSi
Mantra system has received Indian Medical Device regulatory approval (CDSCO) and is clinically validated in India in more than 80 different
types of surgical procedures. SS Innovations has commenced the regulatory approval process in the United States and the European Union
and anticipates receiving FDA approval to market and CE Mark approval in the second half of 2025.
Forward-Looking Statements:
This press release may contain statements that
are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995.
The words "anticipate," "assume," "believe," "estimate," "expect," "will,"
"intend," "may," "plan," "project," "should," "could," "seek,"
"designed," "potential," "forecast," "target," "objective," "goal,"
or the negatives of such terms or other similar expressions to identify such forward-looking statements. These statements relate to future
events or SS Innovations International, Inc.'s future financial performance and involve known and unknown risks, uncertainties and
other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any
future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.
For media inquiries, please contact: